Clinical trial · Interventional
The 5-FU Holter Study
Feasibility Study of Ambulatory Holter Monitoring While Receiving Infusional Fluorouracil (5-FU) Chemotherapy
NCT06538610CI-TRIAL-00083502recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To assess the feasibility of using ambulatory ECG monitoring (Holter monitor) for patients receiving 5-FU chemotherapy
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastrointestinal Malignancy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Holter monitor | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Holter monitor
- description
- Holter monitor for 48 hours
- interventionNames
- Device: Holter monitor
Primary outcomes (10)
- measure
- Recruitment rate
- timeFrame
- Up to 1 year
- description
- The percentage of participants who were contacted and joined the study will be reported.
- measure
- Acceptability rate
- timeFrame
- Up to 1 year
- description
- The percentage of participants who joined the study and wore the Holter monitor for the required study duration.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with diagnosis of gastrointestinal malignancy * Planned to receive either FOLFOX chemotherapy with any treatment intent * Aged ≥ 18 years at time of signing informed consent form Exclusion Criteria: • ECG with left bundle branch block or left ventricular hypertrophy with strain
References
Publications (0)
Data not yet available
No reference posted for this study.